Literature DB >> 33664950

Intrahepatic intraductal papillary cystic neoplasm of the bile duct: A case report.

Evangelos G Baltagiannis1, Christina Kalyvioti1, Anastasia Glantzouni2, Anna Batistatou3, Petros Tzimas4, Georgios K Glantzounis1.   

Abstract

INTRODUCTION AND IMPORTANCE: Intraductal papillary neoplasm of the bile duct (IPNB) is a tumour with a very low incidence in the Western world, characterised by a high risk of malignant transformation and unknown prognosis. It is a new entity which was adopted by the WHO in 2010 as a precursor lesion of cholangiocarcinoma. Intrahepatic bile duct is the most common site of origin for IPNB. CASE
PRESENTATION: Hereby, we present a case of an asymptomatic 63- year-old man, referred to our department after routine ultrasonography showing a multifocal cystic lesion on the left hepatic lobe. Further screening modalities (CT, MRI abdo) confirmed a complex cystic liver lesion with atypical features. The patient underwent left hepatectomy. Histopathology showed a cystic type intrahepatic IPNB, which was completely resected (R0). The follow up in 2 yrs post-operation showed no signs of recurrence. CLINICAL DISCUSSION: The diagnosis and management of IPNB remain challenging. A multimodality imaging approach is essential in order to diagnose IPNB, assess tumour location and extent and plan the optimal treatment strategy.
CONCLUSION: Complete surgical resection (R0) with close postoperative follow-up offers long-term survival.
© 2021 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.

Entities:  

Keywords:  Case report; Cystic liver lesion; Diagnosis; Intraductal papillary neoplasm of the bile duct; Liver resection; Management

Year:  2021        PMID: 33664950      PMCID: PMC7900680          DOI: 10.1016/j.amsu.2021.02.013

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


  19 in total

Review 1.  Intraductal Papillary Neoplasm of the Bile Duct: Clinical, Imaging, and Pathologic Features.

Authors:  Hyo Jung Park; So Yeon Kim; Hyoung Jung Kim; Seung Soo Lee; Gil Sun Hong; Jae Ho Byun; Seung-Mo Hong; Moon-Gyu Lee
Journal:  AJR Am J Roentgenol       Date:  2018-04-09       Impact factor: 3.959

2.  Intraductal papillary neoplasm of the bile duct: A rare liver tumor complicated by malignancy.

Authors:  Kentaro Tominaga; Kenya Kamimura; Akira Sakamaki; Shuji Terai
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

3.  The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines.

Authors:  Riaz A Agha; Thomas Franchi; Catrin Sohrabi; Ginimol Mathew; Ahmed Kerwan
Journal:  Int J Surg       Date:  2020-11-09       Impact factor: 6.071

4.  Diagnostic performance of CT and MRI in distinguishing intraductal papillary neoplasm of the bile duct from cholangiocarcinoma with intraductal papillary growth.

Authors:  Yubao Liu; Xiaomei Zhong; Lifen Yan; Junhui Zheng; Zaiyi Liu; Changhong Liang
Journal:  Eur Radiol       Date:  2015-02-26       Impact factor: 5.315

5.  Recurrence After Resection for Intraductal Papillary Neoplasm of Bile Duct (IPNB) According to Tumor Location.

Authors:  Yunghun You; Seong Ho Choi; Dong Wook Choi; Jin Seok Heo; In Woong Han; Kee-Taek Jang; Sunjong Han
Journal:  J Gastrointest Surg       Date:  2019-05-06       Impact factor: 3.452

6.  Prognostic delineation of papillary cholangiocarcinoma based on the invasive proportion: a single-institution study with 184 patients.

Authors:  Shunsuke Onoe; Yoshie Shimoyama; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Shigeo Nakamura; Masato Nagino
Journal:  Surgery       Date:  2013-11-25       Impact factor: 3.982

7.  Clinicopathologic analysis of intraductal papillary neoplasm of bile duct: Korean multicenter cohort study.

Authors:  Jae Ri Kim; Kee-Taek Jang; Jin-Young Jang; Kyungbun Lee; Jung Hoon Kim; Haeryoung Kim; Sun-Whe Kim; Wooil Kwon; Dong Wook Choi; JinSeok Heo; In Woong Han; Shin Hwang; Wan-Joon Kim; Seung-Mo Hong; Dong-Sik Kim; Young-Dong Yu; Joo Young Kim; Yang Won Nah; Hyung Woo Park; Hye-Jeong Choi; Ho-Seong Han; Yoo-Seok Yoon; Sang Jae Park; Eun Kyung Hong; Hyung Il Seo; Do Youn Park; Koo Jeong Kang; Yu Na Kang; Hee Chul Yu; Woo Sung Moon; Chang-Sup Lim; Jeong Mo Bae; Sungho Jo; Wonae Lee; Young Hun Roh; Jin Sook Jeong; Chi-Young Jeong; Jong Sil Lee; In-Sang Song; Kyung-Hee Kim; Ho Gak Kim; Chang Ho Cho; Sun-Hyung Joo; Kyu Yeoun Won; Hong Jin Kim; Joon Hyuk Choi; Chong-Woo Chu; Jung Hee Lee; Il Young Park; Heejeong Lee; Seung Eun Lee; Hee Sung Kim; Hyeon Kook Lee; Min-Sun Cho; Hongbeom Kim; Kang Min Han
Journal:  HPB (Oxford)       Date:  2019-12-11       Impact factor: 3.647

8.  The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.

Authors:  Xu-Feng Zhang; Malcolm H Squires; Fabio Bagante; Cecilia G Ethun; Ahmed Salem; Sharon M Weber; Thuy Tran; George Poultsides; Andre Y Son; Ioannis Hatzaras; Linda Jin; Ryan C Fields; Matthew Weiss; Charles Scoggins; Robert C G Martin; Chelsea A Isom; Kamron Idrees; Harveshp D Mogal; Perry Shen; Shishir K Maithel; Carl R Schmidt; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2018-02-22       Impact factor: 5.344

9.  Comparison of the Clinicopathologic Characteristics of Intraductal Papillary Neoplasm of the Bile Duct according to Morphological and Anatomical Classifications.

Authors:  Jae Ri Kim; Kyoung-Bun Lee; Wooil Kwon; Eunjung Kim; Sun-Whe Kim; Jin-Young Jang
Journal:  J Korean Med Sci       Date:  2018-09-17       Impact factor: 2.153

10.  Long-term growth of intrahepatic papillary neoplasms: A case report.

Authors:  Takumu Hasebe; Koji Sawada; Hidemi Hayashi; Shunsuke Nakajima; Hiroyuki Takahashi; Masahiro Hagiwara; Koji Imai; Sayaka Yuzawa; Mikihiro Fujiya; Hiroyuki Furukawa; Toshikatsu Okumura
Journal:  World J Gastroenterol       Date:  2019-09-28       Impact factor: 5.742

View more
  1 in total

1.  Surgical Treatment of Intraductal Papillary Neoplasm of the Bile Duct: A Report of Two Cases and Review of the Literature.

Authors:  Binjie Li; Zhiqiang Liu; Zhuo Meng; Mingyang Li; Weijun Tian; Quanyan Liu
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.